首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1738824

2026 年至 2032 年神經復健設備市場（按產品、應用、最終用戶和地區）

Neurorehabilitation Devices Market By Product (Neurorobotic Systems, Brain Computer Interface), Application (Stroke, Parkinson's Disease, Brain & Spinal Cord Injury), End-User (Rehabilitation Centers, Hospitals & Clinics), & Region for 2026-2032

出版日期: 2025年05月06日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

神經復健設備市場評估 - 2026-2032

中風、帕金森氏症和脊髓損傷等神經系統疾病的發生率不斷上升，是神經復健設備市場的主要促進因素。隨著全球人口老化，這些疾病的發生率也不斷上升，導致對有效復健方案的需求龐大。科技的進步正在推動新型神經復健設備的開發，這些設備可以改善患者的康復效果並提高患者的獨立性。所有這些因素都推動了對神經復健設備的需求不斷成長。預計到2024年，市場規模將達到24.6643億美元，到2032年將達到約63.7374億美元。

對早期療育和以患者為中心的治療的日益重視正在推動市場擴張。神經復健設備在改善神經病變患者的生活品質方面發揮關鍵作用，因為它能夠加快復健速度並增強功能。政府的支持措施和不斷成長的醫療支出為市場成長創造了有利的環境。這些因素共同推動了神經復健設備市場的顯著成長。對經濟高效的神經復健設備的需求不斷成長，使得該市場在2026-2032年期間的複合年成長率達到13.90%。

神經復健設備市場定義/概述

神經復健設備是幫助神經系統疾病患者恢復或改善其運動、感覺和認知能力的專用設備。這些設備使用機器人、虛擬實境和腦機介面等不同技術來輔助復健過程。中風、創傷性腦損傷和神經退化性疾病等疾病可透過結構化和客製化的療法進行治療，旨在改善神經元的可塑性和功能恢復。

神經復健設備正在臨床環境中使用，並提供個人化的復健方案以改善患者的治療效果：例如，機器人外骨骼透過引導肢體運動幫助中風患者恢復運動功能，虛擬實境系統為認知和運動練習提供有趣的環境。

隨著人工智慧和機器學習的不斷進步，這些設備能夠更好地適應患者的獨特需求，前景看好。即時神經回饋和更先進的腦機介面預計將透過客製化和改進治療方案，提高神經病變患者的復健率和生活品質。

哪些因素推動了神經復健設備市場需求的激增？

預計神經復健設備市場將在預測期內推動技術進步。機器人技術、虛擬實境和腦機介面技術的進步正在增強這些設備的功能，使其在神經復健中發揮更大的作用。美國國家神經疾病與中風研究所 (NINDS) 在神經科學研究方面投入巨資，在 2020 會計年度撥款約 22.7 億美元，彰顯了其致力於開發新型神經復健技術的決心。預計這項投資將加速改進型復健技術的開發和應用，從而推動市場成長。

醫療保健支出的增加可能會推動神經復健設備市場的成長。醫療保健支出的大幅成長，例如美國全國醫療保健支出在2020年成長9.7%，達到4.1兆美元，顯示人們越來越致力於投資最新的醫療技術。全球醫療保健支出的這種趨勢透過增加這些技術的可及性並促進市場擴張，支持尖端神經復健設備的廣泛應用。

患者的依從性將如何阻礙神經復健設備市場的成長？

患者的依從性對神經復健設備市場的成長至關重要，因為它會影響這些技術的有效性和普及程度。患者對既定復健方案的依從性高，可帶來更好的治療效果，進而增加對神經復健設備的需求。如果患者積極參與治療並遵循治療計劃，康復計畫的成功率將會提高，這不僅能證明這些設備的效用，還能鼓勵進一步的投資和發展。另一方面，依從性低可能會降低設備的有效性，從而減緩市場成長。因此，提高患者的參與度和依從性對於維持和發展神經復健設備市場至關重要。

神經康復器材價格高昂，限制了其可近性和可負擔性，影響了市場成長。昂貴的技術可能會限制其在資金充足的醫療機構和富裕患者的使用，從而限制其廣泛普及並減緩市場成長。雖然技術發展可能會刺激創新並改善療效，但經濟障礙仍然是一個主要問題。透過製造突破、增強競爭和提供經濟高效的解決方案來應對成本挑戰，對於提高這些器械的可及性並推動市場成長至關重要。

In the neurorehabilitation devices market, the increased prevalence of neurological illnesses, such as stroke, Parkinson's disease, and spinal cord injuries, is a major driver. As the world population ages, the prevalence of these illnesses rises, resulting in a significant demand for effective rehabilitation options. Technological improvements have resulted in the development of novel neurorehabilitation devices that improve patient outcomes and increase independence. These factors all contribute to the growing need for neurorehabilitation devices. The market size surpass USD 2466.43 Million valued in 2024 to reach a valuation of around USD 6373.74 Million by 2032.

The growing emphasis on early intervention and patient-centered care is driving market expansion. Neurorehabilitation devices serve an important role in improving the quality of life for people with neurological impairments by allowing for speedier recovery and increased functional capacities. Supportive government measures and rising healthcare expenditures are creating a favorable environment for the market's growth. These combined factors are generating significant growth in the neurorehabilitation device market. The rising demand for cost-effective and efficient neurorehabilitation devices is enabling the market grow at a CAGR of 13.90% from 2026 to 2032.

Neurorehabilitation Devices Market: Definition/ Overview

Neurorehabilitation devices are specialized instruments that help people with neurological abnormalities regain or improve their motor, sensory, and cognitive abilities. These devices use a variety of technologies to aid in the rehabilitation process, including robotics, virtual reality, and brain-computer interfaces. They treat disorders such as stroke, traumatic brain injury, and neurodegenerative diseases using structured and customized therapy that aims to improve neuronal plasticity and functional recovery.

Neurorehabilitation devices are utilized in clinical settings to provide individualized rehabilitation regimens that improve patient results. For instance, robotic exoskeletons aid stroke sufferers in regaining motor function by guiding limb movements, whilst virtual reality systems provide interesting environments for cognitive and motor practice.

These devices show promise, with continual advances in artificial intelligence and machine learning improving their ability to adapt to unique patient demands. Real-time neurofeedback and more advanced brain-computer interfaces are projected to customize and improve therapy, thereby increasing recovery rates and quality of life for those with neurological disabilities.

What are the Factors that Surge the Demand for the Neurorehabilitation Devices Market?

The neurorehabilitation devices market are expected to propel the technological developments over the forecast period. Robotics, virtual reality, and brain-computer interface advances are boosting these devices' capabilities, making them more useful in neurological recovery. The National Institute of Neurological Disorders and Stroke (NINDS) has made a significant investment in neuroscience research, allocating nearly USD 2.27 Billion for fiscal year 2020, demonstrating its commitment to creating novel neurorehabilitation technology. This investment is likely to speed the development and implementation of improved rehabilitation techniques, hence boosting market growth.

The increase in healthcare expenditure is likely to boost the growth of the neurorehabilitation devices market. The significant increase in healthcare spending, as seen by a 9.7% increase to USD 4.1 Trillion in US national health spending in 2020, demonstrates an increasing commitment to investing in modern medical technology. This global growing trend in healthcare expenditure supports the broader adoption of cutting-edge neurorehabilitation devices by increasing access to these technologies and promoting market expansion.

How Does the Patient Compliance Hinder the Growth of the Neurorehabilitation Devices Market?

Patient compliance has a substantial impact on the growth of the neurorehabilitation device market because it influences the effectiveness and adoption of these technologies. High levels of patient compliance with prescribed rehabilitation regimens result in better outcomes, driving demand for neurorehabilitation devices. When patients are engaged and follow their therapy plans, rehabilitation program success rates improve, indicating the utility of these devices and driving further investment and development. Low compliance, on the other hand, can reduce a device's perceived effectiveness, thus slowing market growth. As a result, improving patient involvement and compliance is critical for maintaining and developing the neurorehabilitation devices market.

The high cost of neurorehabilitation devices has an impact on market growth by limiting access and affordability. Expensive technologies may limit their use to well-funded healthcare facilities or rich patients, restricting widespread adoption and slowing market growth. Although technological developments may promote innovation and enhance outcomes, the financial barrier continues to be a significant problem. Addressing cost challenges through manufacturing breakthroughs, increased competition, and cost-effective solutions is essential to making these devices more accessible and driving market growth.

Category-Wise Acumens

Will the Demand for Robotic Arms Propel the Neurorobotic Systems Segment?

Neurorobotic systems are now dominating the neurorehabilitation device market. Robotic arms are expected to create substantial expansion in the neurorobotic systems section of the neurorehabilitation device market. These modern robotic technologies improve the precision and effectiveness of rehabilitation by offering consistent and controlled support during therapy. Robotic arms improve patient outcomes by allowing for repetitive, task-specific exercises that promote neuronal plasticity, driving demand for neurorobotic systems. Their increasing integration into rehabilitation programs highlights their potential to transform neurorehabilitation, hence driving market growth in this category.

Exoskeletons are expected to fuel expansion in the neurorobotic systems section of the neurorehabilitation devices market. These exoskeletons provide total support and assistive mobility, improving the rehabilitation process by allowing patients with severe motor impairments to participate in meaningful physical activities. Their capacity to aid functional recovery through repetitive, regulated movements while also providing support during therapy makes them extremely effective in neurorehabilitation. The use of encompassing exoskeletons is expected to greatly boost the neurorobotic systems market, highlighting their expanding importance in advanced rehabilitation procedures.

The capacity to assess and quantify patient performance using these technologies has resulted in better treatment outcomes, making them the favored option for many rehabilitation centers.

Will the Trained Professionals Fuel the Hospitals & Clinics Segment for the Neurorehabilitation Devices Market?

The hospitals & clinics segment currently dominates the neurorehabilitation devices market. The presence of trained professionals will fuel expansion in the neurorehabilitation devices market's hospital and clinic segments. Skilled healthcare personnel are required to successfully adopt and optimize the use of modern neurorehabilitation technologies. Their knowledge ensures that patients receive proper, individualized therapy, allowing these devices to provide the most benefit possible. As hospitals and clinics continue to spend on training and hiring experienced personnel, they improve the quality and effectiveness of neurorehabilitation services, attracting more patients and increasing demand for these devices in the healthcare sector.

The neurorehabilitation devices market will propel the hospital and clinic segment combination of advanced facilities and trained experts. Advanced facilities equipped with cutting-edge neurorehabilitation devices, as well as qualified experts capable of utilizing this technology, ensure high-quality, tailored patient treatment. This collaboration improves the effectiveness of rehabilitation programs, bringing more patients to hospitals and clinics for treatment. As a result, demand for neurorehabilitation devices rises in these settings, driving market expansion in this sector.

Country/Region-wise Acumens

Will the Advanced Research and Development Boost the North American Region for the Neurorehabilitation Devices Market?

North America, holds a dominant position in the neurorehabilitation devices market. Advanced research and development are propelling the neurorehabilitation devices market in North America. The United States, in particular, is driving this effort with significant investments in neurological research and rehabilitation technologies. The National Institutes of Health (NIH) will spend around USD 9.7 Billion on brain research in fiscal year 2023, with a large chunk of that going toward neurorehabilitation. The National Institute of Neurological Disorders and Stroke (NINDS), got USD 2.8 Billion, up 3.5% from the previous year. The high frequency of neurological illnesses, such as 17% of children diagnosed with developmental impairments and 6.7 million Americans aged 65 and older living with Alzheimer's dementia, adds to this demand.

The well-established healthcare infrastructure will propel the neurorehabilitation devices market in North America. The United States and Canada, with their modern medical facilities and high adoption rates of cutting-edge technology, provide an ideal setting for market expansion. According to the American Hospital Association (AHA), there will be 6,093 hospitals in the United States in 2023, many of which will have cutting-edge rehabilitation departments.

The Centers for Medicare & Medicaid Services (CMS) estimated 1,166 inpatient rehabilitation centers in 2021, with specialized intensive care. The high prevalence of neurological illnesses, with the CDC estimating 795,000 strokes each year in the United States and the National Spinal Cord Injury Statistical Center reporting 17,900 new spinal cord injury cases each year, emphasizes the need for sophisticated neurorehabilitation technologies.

These factors emphasize a sizable patient population that could benefit from such devices, which is boosting demand for effective and novel neurorehabilitation solutions in North America.

Will the Urbanization and Increasing Disposable Incomes Expand the Asian Pacific Region for the Neurorehabilitation Devices Market?

The Asia-Pacific region is experiencing the most rapid growth in the neurorehabilitation devices market. Urbanization and increasing disposable incomes will fuel Asia Pacific's neurorehabilitation device market. Countries such as China, India, and Japan are undergoing fast urbanization and economic development, resulting in increased access to healthcare services and innovative medical technologies. According to UNESCAP, the region's urban population is expected to increase from 2.3 billion in 2019 to 3.5 billion by 2050, while the World Bank reports that GDP per capita in East Asia and the Pacific increased from $10,291 in 2010 to $14,480 in 2021, indicating a significant increase in purchasing power.

The prevalence of neurological disorders underscores this requirement, with the World Health Organization estimating that neurological disorders account for 6.8% of the overall disease burden in the Western Pacific and 8.7% in Southeast Asia. Furthermore, a 2023 study in The Lancet Neurology predicts that the number of persons with dementia in Asia Pacific will rise from 20.1 million in 2020 to 61.4 million by 2050. These considerations highlight the growing patient population in the Asia Pacific who could benefit from neurorehabilitation equipment, which is being driven by urbanization, increased incomes, and an increase in the prevalence of neurological illnesses.

Expanding healthcare awareness will drive the Asia Pacific neurorehabilitation devices market. In North America, rising public health education and patient empowerment in nations such as China, India, and Japan are leading to a greater understanding of neurological diseases and the benefits of rehabilitation therapies. As awareness rises, the region's large population of people suffering from neurological illnesses learns more about the importance of neurorehabilitation. This increased awareness, combined with a focus on improving long-term care and quality of life, is generating strong demand for neurorehabilitation equipment in the Asia Pacific region.

Competitive Landscape

The neurorehabilitation devices market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the neurorehabilitation devices market include:

Bionik Labs
Ectron Ltd.
REHABTRONICS INC.
DIH International Limited (Hocoma AG)
Abbott Laboratories (St. Jude Medical Inc.)
MagVenture A/S
Helius Medical Technologies
Ekso Bionics
Rehab-Robotics Company Limited
Neurodan
Rex Bionics
Ottobock SE & Co. KGaA
NeuroMetrix, Inc.

Latest Developments

In February 2023, MindMaze debuted Iza, a US Food and Drug Administration (FDA)-listed and CE-marked smart peripheral device for patients with weak hand motor abilities. Izar is intended to address a major vacuum in neurological care by providing the most effective treatment for manual dexterity and strength in a variety of neurological diseases.
In September 2022, Sumitomo Pharma Co. Ltd. and MELTIN MMI agreed to launch and commercialize the MELTz(R) Hand Rehabilitation System. The product was co-developed by the aforementioned companies, but MELTIN acquired device certification as a distributor and manufacturer.
In April 2022, Blackrock Neurotech purchased MindX to accelerate the development of highly superior brain-computer interface technologies. By merging its hardware DNA with MindX's software DNA, Blackrock hoped to increase neural data analysis while also providing flexibility and adaptation for a wide range of BCI applications.